Aziyo biologics to participate in the lytham partners spring 2022 investor conference

Silver spring, md., march 31, 2022 (globe newswire) -- aziyo biologics, inc. (nasdaq: azyo), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that it will be participating in the lytham partners spring 2022 investor conference taking place virtually on april 4-7, 2022.
AZYO Ratings Summary
AZYO Quant Ranking